Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
“A blog about allergy, asthma & immunology”
Few studies have been conducted on the potential links between various irritants and food allergies.
“A blog about allergy, asthma & immunology”
The mechanisms that make and break CD8+ T cell tolerance to self-antigens remain unclear. In this issue of Immunity, Van Der Byl et al. show that tolerant…
Probiotics have been hypothesized to mediate inflammation through gut microbiome modulation. Spondyloarthropathies have subclinical gut inflammation associated with inflammatory disease that may benefit from probiotic…
A major barrier to antitumor immunity in solid tumors is T cell exclusion. In this issue of Immunity, De Sanctis et al. elucidate how CLDN18 on pancreatic…
Malat1-overexpressing tumors secrete Ccl2 to promote macrophage recruitment and lung adenocarcinoma progression.
Inadequate payments could force some docs to stop accepting Medicare patients, commission warns
Despite experiencing symptoms, roughly 70% of people with chronic obstructive pulmonary disease (COPD) and asthma do not know they have the condition. They also tend…
Phagocytic microglia such as proliferative region-associated microglia and disease-associated microglia appear in the brain transiently during development and across various brain pathologies, but their function…